S. Tyring

发表

Interferon-mediated protection of B16 melanoma cells from cytotoxicity by activated macrophages.

S. Baron, M. Sarzotti, S. Tyring, 1986, Cellular immunology.

Association Between β-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-A Meta-analysis.

S. Tyring, J. Chahoud, P. Rady, 2016, JAMA dermatology.

Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients.

S. Tyring, P. Rady, J. Fish, 1998, The Journal of infectious diseases.

Relation between herpes simplex viruses and human immunodeficiency virus infections.

S. Tyring, J. Severson, Stephen K. Tyring, 1999, Archives of dermatology.

The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes.

S. Tyring, J. Fine, W. Gammon, 1989, The Journal of investigative dermatology.

Famciclovir: review of clinical efficacy and safety.

S. Tyring, Patricia C. Lee, K. Herne, 1996, Antiviral research.

Natural killer cell activity is reduced in patients with severe forms of inherited epidermolysis bullosa.

S. Tyring, J. Fine, V. Chopra, 1989, Archives of dermatology.

Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapy.

S. Tyring, B. Berman, D. Whiting, 1992, Archives of dermatology.

Molecular diagnosis of infectious diseases in dermatology.

S. Tyring, Jashin J. Wu, P. Rady, 2004, Journal of the American Academy of Dermatology.